Sanofi· @sanofi · X·· 2026-06-19精选AI 评分60
AI 导读
日本厚生劳动省批准赛诺菲的皮下制剂联合已批准的标准治疗方案，用于治疗多发性骨髓瘤。赛诺菲通过官方账号发布了这一消息，并附上完整公告链接。
推荐理由
日本厚生劳动省批准赛诺菲皮下制剂联合标准疗法治疗多发性骨髓瘤，读者可了解该药在日本市场的适应症扩展。
正文
The Ministry of Health, Labour and Welfare in Japan has approved our subcutaneous therapy in combination with approved standard-of-care regimens for the treatment of multiple myeloma. Read the full announcement here: https://www.sanofi.com/en/media-room/press-releases/2026/2026-06-19-10-31-15-3314694
来源：Sanofi · x.com